Biomarkers for Targeted Therapies and Immune Checkpoint Inhibitors in Advanced NSCLC

被引：0
|
作者：
Wang, Jie [1 ]
机构：
[1] Chinese Acad Med Sci, Canc Hosp, Thorac Med Oncol, Beijing, Peoples R China
来源：
JOURNAL OF THORACIC ONCOLOGY | 2017年 / 12卷 / 01期
关键词：
Immune checkpoint inhibitors; biomarker; dynamic change; Targeted Therapies;
D O I：
10.1016/j.jtho.2016.11.142
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
MTE09.01
引用
收藏
页码：S157 / S158
页数：2
相关论文
共 50 条
  • [1] Circulating Extracellular Vesicles as Biomarkers for Immune-Checkpoint Inhibitors in Advanced NSCLC
    Signorelli, D.
    Fortunato, O.
    Pontis, F.
    Capizzuto, V.
    Ferri, R.
    Brambilla, M.
    Ferrara, R.
    Proto, C.
    Lo Russo, G.
    Prelaj, A.
    Galli, G.
    De Toma, A.
    Viscardi, G.
    Lobefaro, R.
    Nichetti, F.
    Ganzinelli, M.
    Zilembo, N.
    Colombo, M.
    Sozzi, G.
    Garassino, M. C.
    Jachetti, E.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (03) : S405 - S405
  • [2] Mechanism and potential predictive biomarkers of immune checkpoint inhibitors in NSCLC
    Qu, Jialin
    Jiang, Man
    Wang, Li
    Zhao, Deze
    Qin, Kang
    Wang, Yun
    Tao, Junyan
    Zhang, Xiaochun
    BIOMEDICINE & PHARMACOTHERAPY, 2020, 127
  • [3] Oral mucosal changes induced by anticancer targeted therapies and immune checkpoint inhibitors
    Vigarios, Emmanuelle
    Epstein, Joel B.
    Sibaud, Vincent
    SUPPORTIVE CARE IN CANCER, 2017, 25 (05) : 1713 - 1739
  • [4] Oral mucosal changes induced by anticancer targeted therapies and immune checkpoint inhibitors
    Emmanuelle Vigarios
    Joel B. Epstein
    Vincent Sibaud
    Supportive Care in Cancer, 2017, 25 : 1713 - 1739
  • [5] Immune Checkpoint Inhibitors in NSCLC
    Johnson, Douglas B.
    Rioth, Matthew J.
    Horn, Leora
    CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2014, 15 (04) : 658 - 669
  • [6] Immune Checkpoint Inhibitors in NSCLC
    Douglas B. Johnson
    Matthew J. Rioth
    Leora Horn
    Current Treatment Options in Oncology, 2014, 15 : 658 - 669
  • [7] Immune Checkpoint Inhibitors in Lung Cancer: Role of Biomarkers and Combination Therapies
    Maung, Tun Zan
    Ergin, Huseyin Ekin
    Javed, Mehwish
    Inga, Evelyn E.
    Khan, Safeera
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2020, 12 (05)
  • [8] Biomarkers for immune checkpoint inhibitors in advanced nonsmall cell lung cancer
    Pirker, Robert
    CURRENT OPINION IN ONCOLOGY, 2019, 31 (01) : 24 - 28
  • [9] PD-L1 SNPs as biomarkers to define benefit in patients with advanced NSCLC treated with immune checkpoint inhibitors
    Minari, Roberta
    Bonatti, Francesco
    Mazzaschi, Giulia
    Dodi, Alessandra
    Facchinetti, Francesco
    Gelsomino, Francesco
    Cinquegrani, Gloria
    Squadrilli, Anna
    Bordi, Paola
    Buti, Sebastiano
    Bersanelli, Melissa
    Leonetti, Alessandro
    Cosenza, Agnese
    Ferri, Leonarda
    Rapacchi, Elena
    Quaini, Federico
    Ardizzoni, Andrea
    Tiseo, Marcello
    TUMORI JOURNAL, 2022, 108 (01): : 47 - 55
  • [10] Biomarkers for immune Checkpoint inhibitors in Melanoma
    Kitano, Shigehisa
    Nakayama, Takayuki
    Yamashita, Makiko
    FRONTIERS IN ONCOLOGY, 2018, 8
12345